Insider · CIK 0001910662
Nicole LaBrosse
cfoofficer
Files at HALO (HALOZYME THERAPEUTICS, INC.). First filing Sep 11, 2025, latest Sep 23, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.7M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HALO: HALOZYME THERAPEUTICS, INC.
HALOOct 9, 2026 · close 110.42
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | HALOZYME THERAPEUTICS, INC. | $174k 2,227 shares | -9% | +84% from low0% from high | |
| 37Weak | HALOZYME THERAPEUTICS, INC. | $1.5M 20,000 shares | -45% | +78% from low-0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,913 | $77.83 | $149k | 22,393 | Sep 23, 2025 |
| Sep 22, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -314 | $78.67 | $25k | 22,079 | Sep 23, 2025 |
| Sep 10, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +11,271 | $12.07 | $136k | 43,171 | Sep 11, 2025 |
| Sep 10, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +1,135 | $12.49 | $14k | 44,306 | Sep 11, 2025 |
| Sep 10, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,760 | $75.29 | $509k | 37,546 | Sep 11, 2025 |
| Sep 10, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -13,240 | $75.93 | $1.0M | 24,306 | Sep 11, 2025 |
| Sep 10, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -11,271 | $0.00 | $0 | 0 | Sep 11, 2025 |
| Sep 10, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -1,135 | $0.00 | $0 | 812 | Sep 11, 2025 |
| Feb 23, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock | +6,688 | $0.00 | $0 | 35,501 | Feb 24, 2025 |
| Feb 23, 2025 | HALO HALOZYME THERAPEUTICS, INC. | FTax withholding Common Stock | -3,601 | $57.75 | $208k | 31,900 | Feb 24, 2025 |
| Feb 23, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -6,688 | $0.00 | $0 | 20,063 | Feb 24, 2025 |
| Feb 20, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Option to Purchase Common Stockderivative | +22,603 | $0.00 | $0 | 22,603 | Feb 21, 2025 |
| Feb 20, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Restricted Stock Unitsderivative | +21,327 | $0.00 | $0 | 21,327 | Feb 21, 2025 |
| Feb 15, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock | +1,254 | $0.00 | $0 | 16,734 | Feb 18, 2025 |
| Feb 15, 2025 | HALO HALOZYME THERAPEUTICS, INC. | FTax withholding Common Stock | -741 | $58.29 | $43k | 15,993 | Feb 18, 2025 |
| Feb 16, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock | +17,409 | $0.00 | $0 | 33,402 | Feb 18, 2025 |
| Feb 16, 2025 | HALO HALOZYME THERAPEUTICS, INC. | FTax withholding Common Stock | -9,400 | $58.29 | $548k | 24,002 | Feb 18, 2025 |
| Feb 16, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock | +5,093 | $0.00 | $0 | 29,095 | Feb 18, 2025 |
| Feb 16, 2025 | HALO HALOZYME THERAPEUTICS, INC. | FTax withholding Common Stock | -2,742 | $58.29 | $160k | 26,353 | Feb 18, 2025 |
| Feb 16, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock | +5,329 | $0.00 | $0 | 31,682 | Feb 18, 2025 |
| Feb 16, 2025 | HALO HALOZYME THERAPEUTICS, INC. | FTax withholding Common Stock | -2,869 | $58.29 | $167k | 28,813 | Feb 18, 2025 |
| Feb 15, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -1,254 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 16, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Performance Stock Unitsderivative | -17,409 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 16, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -5,093 | $0.00 | $0 | 5,093 | Feb 18, 2025 |
| Feb 16, 2025 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -5,329 | $0.00 | $0 | 10,658 | Feb 18, 2025 |
| Feb 12, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Performance Stock Unitsderivative | +6,050 | $0.00 | $0 | 17,409 | Feb 14, 2025 |
| Feb 12, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Performance Stock Unitsderivative | +5,221 | $0.00 | $0 | 8,184 | Feb 14, 2025 |
| Feb 12, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Performance Stock Unitderivative | +6,935 | $0.00 | $0 | 6,935 | Feb 14, 2025 |
| Feb 12, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Performance Stock Unitsderivative | +28,662 | $0.00 | $0 | 28,662 | Feb 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.